HopeStage
Back to all studies
CompletedNCT00856063

Autonomic Correlates of Impulsivity for Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD)

Medication studyAges 48–70 months
The study in practice

Understand this study

Who was this study for?

This study was for people with ADHD. Listed age limits: 48 months to 70 months. Other eligibility criteria applied.

Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMarch 2009
Recruitment status
Completed
Enrollment listed in the registry
5
Sponsor
University of Arizona
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Not clearly listed
Age range
From 48 Months to 70 Months
Official registry ID
NCT00856063
Official title
Show the full official title

Feasibility and Utility of Autonomic Correlates of Impulsivity in Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD): Extending Translational Research Skills

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Locations not listed

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Arizona, a university.

Did this study involve medication?

Yes. The study involved medication, including atomoxetine (or placebo).

Who was this study for?

This study was for people with ADHD. Listed age limits: 48 months to 70 months. Other eligibility criteria applied.

Want to explore more studies?

Explore studies